Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0388 Transporter Info
Gene Name	SLC4A8
Transporter Name	Electroneutral sodium bicarbonate exchanger 1
Gene ID	9498
UniProt ID	Q2Y0W8

Post-Translational Modification of This DT
Overview of SLC4A8 Modification Sites with Functional and Structural Information
Sequence	M P A A G S N E P D G V L S Y Q R P D E E A V V D Q G G T S T I L N I H Y E K E E L E G H R T L Y V G V R M P L G R Q S H R H H R T H G Q K H R R R G R G K G A S Q G E E G L E A L A H D T P S Q R V Q F I L G T E E D E E H V P H E L F T E L D E I C M K E G E D A E W K E T A R W L K F E E D V E D G G E R W S K P Y V A T L S L H S L F E L R S C L I N G T V L L D M H A N S I E E I S D L I L D Q Q E L S S D L N D S M R V K V R E A L L K K H H H Q N E K K R N N L I P I V R S F A E V G K K Q S D P H L M D K H G Q T V S P Q S V P T T N L E V K N G V N C E H S P V D L S K V D L H F M K K I P T G A E A S N V L V G E V D I L D R P I V A F V R L S P A V L L S G L T E V P I P T R F L F I L L G P V G K G Q Q Y H E I G R S M A T I M T D E I F H D V A Y K A K E R D D L L A G I D E F L D Q V T V L P P G E W D P S I R I E P P K N V P S Q E K R K M P G V P N G N V C H I E Q E P H G G H S G P E L Q R T G R L F G G L V L D I K R K A P W Y W S D Y R D A L S L Q C L A S F L F L Y C A C M S P V I T F G G L L G E A T E G R I S A I E S L F G A S M T G I A Y S L F A G Q A L T I L G S T G P V L V F E K I L F K F C K D Y A L S Y L S L R A C I G L W T A F L C I V L V A T D A S S L V C Y I T R F T E E A F A S L I C I I F I Y E A I E K L I H L A E T Y P I H M H S Q L D H L S L Y Y C R C T L P E N P N N H T L Q Y W K D H N I V T A E V H W A N L T V S E C Q E M H G E F M G S A C G H H G P Y T P D V L F W S C I L F F T T F I L S S T L K T F K T S R Y F P T R V R S M V S D F A V F L T I F T M V I I D F L I G V P S P K L Q V P S V F K P T R D D R G W I I N P I G P N P W W T V I A A I I P A L L C T I L I F M D Q Q I T A V I I N R K E H K L K K G C G Y H L D L L M V A I M L G V C S I M G L P W F V A A T V L S I T H V N S L K L E S E C S A P G E Q P K F L G I R E Q R V T G L M I F V L M G C S V F M T A I L K F I P M P V L Y G V F L Y M G V S S L Q G I Q F F D R L K L F G M P A K H Q P D F I Y L R H V P L R K V H L F T L I Q L T C L V L L W V I K A S P A A I V F P M M V L A L V F V R K V M D L C F S K R E L S W L D D L M P E S K K K K L D D A K K K A K E E E E A E K M L E I G G D K F P L E S R K L L S S P G K N I S C R C D P S E I N I S D E M P K T T V W K A L S M N S G N A K E K S L F N
PTM type	X-Acetylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation
Alanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A8			[1]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	971
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC4A8 Alanine 971 has the potential to affect its expression or activity.
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A8			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1024
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC4A8 Lysine 1024 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A8			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1039
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC4A8 Lysine 1039 has the potential to affect its expression or activity.
Oxidation
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A8			[3]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	276
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC4A8 Cystine 276 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A8			[3]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	863
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC4A8 Cystine 863 has the potential to affect its expression or activity.
Phosphorylation
Alanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A8			[4]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	184
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Alanine 184 has the potential to affect its expression or activity.
Serine	23 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A8			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	6
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 6 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A8			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	14
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 14 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC4A8			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	81
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 81 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC4A8			[4] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	237
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 237 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC4A8			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	246
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 246 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC4A8			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	259
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 259 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC4A8			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	279
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 279 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC4A8			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	284
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 284 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC4A8			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	301
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 301 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC4A8			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	404
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 404 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC4A8			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	475
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 475 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC4A8			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	481
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 481 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC4A8			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	491
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 491 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC4A8			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	626
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 626 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC4A8			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	632
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 632 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SLC4A8			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	727
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 727 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SLC4A8			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	730
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 730 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence SLC4A8			[14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	752
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 752 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence SLC4A8			[15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1002
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 1002 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence SLC4A8			[15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1011
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 1011 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence SLC4A8			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1049
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 1049 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence SLC4A8			[8] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1050
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 1050 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence SLC4A8			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1080
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Serine 1080 has the potential to affect its expression or activity.
Threonine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A8			[12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	495
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Threonine 495 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A8			[12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	504
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Threonine 504 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC4A8			[5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	619
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Threonine 619 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC4A8			[17]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	639
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Threonine 639 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC4A8			[17]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	648
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Threonine 648 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC4A8			[18]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	764
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Threonine 764 has the potential to affect its expression or activity.
Tyrosine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A8			[5]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	15
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Tyrosine 15 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A8			[19]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	49
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Tyrosine 49 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC4A8			[12]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	486
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Tyrosine 486 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC4A8			[5]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	620
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Tyrosine 620 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC4A8			[5]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	634
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Tyrosine 634 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC4A8			[5]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	635
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Tyrosine 635 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC4A8			[17]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	651
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A8 Tyrosine 651 has the potential to affect its expression or activity.
Ubiquitination
Asparticacid	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A8			[4]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	25
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A8 Asparticacid 25 has the potential to affect its expression or activity.
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A8			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	78
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A8 Lysine 78 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A8			[20]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1012
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A8 Lysine 1012 has the potential to affect its expression or activity.

References
1	Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009 Aug 14;325(5942):834-40.
2	Suicide risk in placebo-controlled studies. Am J Psychiatry. 2002 Apr;159(4):680-1; author reply 681.
3	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
4	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
5	Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
6	Comprehensive quantitative comparison of the membrane proteome, phosphoproteome, and sialiome of human embryonic and neural stem cells. Mol Cell Proteomics. 2014 Jan;13(1):311-28.
7	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
8	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
9	Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome. Proteomics. 2015 Jan;15(2-3):500-7.
10	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
11	An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
12	Integrative proteomic analysis reveals reprograming tumor necrosis factor signaling in epithelial mesenchymal transition. J Proteomics. 2016 Oct 4;148:126-38.
13	An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62.
14	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
15	Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
16	CEP128 Localizes to the Subdistal Appendages of the Mother Centriole and Regulates TGF-beta/BMP Signaling at the Primary Cilium. Cell Rep. 2018 Mar 6;22(10):2584-2592.
17	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
18	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
19	Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts. PLoS Comput Biol. 2015 Apr 17;11(4):e1004130.
20	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence